Role of CEACAM1 and CEACAM20 in an in vitro model of prostate morphogenesis

Hui Zhang1, Andreas Eisenried, Wolfgang Zimmermann

  • 1City of Hope Irell & Manella Graduate School of Biological Sciences, Duarte, California, USA.

Plos One
|January 30, 2013
PubMed

Insights

Carcinoma antigen 20 (CEACAM20) and CEACAM1 are crucial for prostate organoid lumen formation. Their down-regulation in prostate cancer highlights their role in maintaining normal prostate epithelium structure.

Area of Science:

  • Cell biology
  • Molecular biology
  • Urology

Background:

  • Carcinoma antigen 20 (CEACAM20) is a CEACAM1 family member expressed in the small intestine, testes, and prostate.
  • CEACAM20 and CEACAM1 are co-expressed in adult prostate tissue and downregulated in prostate cancer.
  • Prostate cancer often involves the loss of epithelial lumen formation, suggesting a role for CEACAMs.

Purpose of the Study:

  • To investigate the role of CEACAM20 and CEACAM1 in the lumen formation of normal prostate epithelium.
  • To understand the function of CEACAM20 and CEACAM1 in the in vitro generation of prostate organoids.

Main Methods:

  • Prostate cells were cultured on Matrigel to induce differentiation into acinar structures.
  • Confocal microscopy was used to analyze the localization of CEACAM20 and CEACAM1.
  • Inhibition of CEACAM1 and CEACAM20 was achieved using antibodies and antisense oligonucleotides.

Main Results:

  • CEACAM20 localized to acini, while CEACAM1 localized to tubule structures in differentiated prostate organoids.
  • Inhibition of CEACAM1 reduced tubule formation by over 50% and caused stunting.
  • Inhibition of CEACAM20 completely blocked tubule formation and stunted acinar growth.

Conclusions:

  • CEACAM20 and CEACAM1 are not only markers of adult prostate lumina but are critical for in vitro prostate organoid generation.
  • These findings suggest a significant role for CEACAM20 and CEACAM1 in maintaining prostate epithelial structure and lumen integrity.

Related Concept Videos